UK court awards Apotex £17.5 million in Servier case
This article was originally published in Scrip
Executive Summary
Apotexhas been awarded damages of £17.5 million from Servierin a long-running UK patent dispute over perindopril. Mr Justice Norris of the High Court's Chancery division estimated that the amount would adequately compensate Apotex for profits that it lost during a period when it was prevented by injunction from selling a generic version of Coversyl.